County
Wilson County Emergency Management Agency
The current listed document is more than 24 months old and may be outdated.
Drugs and doses31
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride7
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 15 mg/kg | PO | not captured | standing | page 52 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 52 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 0.1 mg/kg | IV | not captured | standing | page 34 |
| SVT | adult | 12 mg | IV | not captured | standing | page 34 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 34 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 2.5 mg | NEB | not captured | standing | page 60 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | page 32 |
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | page 39 |
| Wide-complex tachycardia | adult | 5 mg/kg | IV | not captured | standing | page 39 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV | not captured | standing | page 39 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 37 |
| VF / pulseless VT | adult | 5 mg/kg | IV | not captured | standing | page 37 |
| VF / pulseless VT | peds | 5 mg/kg | IV | not captured | standing | page 37 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 46 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.02 mg/kg | IV/IO | not captured | standing | page 27 |
| Bradycardia | adult | 0.5–1 mg | IV/IO | not captured | standing | page 26 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 27 |
| Organophosphate poisoning | adult | 0.05 mg/kg | IV/IO | not captured | standing | page 86 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | page 86 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 86 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 20 mg/kg | IV/IO | not captured | standing | page 22 |
| Cardiac arrest | adult | 500–1000 mg | IV/IO | not captured | standing | page 22 |
| Cardiac arrest | peds | 20 mg/kg | IV/IO | not captured | standing | page 22 |
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Fentanyl7
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mL/kg | IV | not captured | standing | page 55 |
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | page 55 |
| Hypoglycemia | adult | 2 mL/kg | IV | not captured | standing | page 55 |
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 55 |
| Hypoglycemia | adult | 4 mL/kg | IV | not captured | standing | page 55 |
| Hypoglycemia | peds | 2 mL/kg | IV | not captured | standing | page 55 |
| Hypoglycemia | peds | 4 mL/kg | IV | not captured | standing | page 55 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.2 mg/kg | IV | not captured | standing | page 146 |
| Procedural sedation | adult | 5 mg | IV | not captured | standing | page 146 |
| Procedural sedation | peds | 0.2 mg/kg | IV | not captured | standing | page 146 |
| Seizure | adult | 0.2 mg/kg | IV/IO | not captured | standing | page 65 |
| Seizure | adult | 0.5 mg/kg | PR | not captured | standing | page 65 |
| Seizure | adult | 2–5 mg | IV/IO | not captured | standing | page 65 |
| Seizure | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 65 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 65 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 23 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 42 |
| Allergic reaction | adult | 25 mg | IV | not captured | standing | page 42 |
| Allergic reaction | adult | 50 mg | IM | not captured | standing | page 42 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 42 |
| Anaphylaxis | adult | 1 mg/kg | IV/IO/IM | not captured | standing | page 43 |
| Anaphylaxis | adult | 25 mg | IV | not captured | standing | page 43 |
| Anaphylaxis | adult | 50 mg | IM | not captured | standing | page 43 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 43 |
| Other | adult | 50 mg | IV/IO/IM | not captured | standing | page 58 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–20 mcg/kg | IV | not captured | standing | page 26 |
| Cardiogenic shock | adult | 2–20 mcg/kg | IV | not captured | standing | page 107 |
| Hypotension / shock | adult | 2–20 mcg/kg | IV | not captured | standing | page 109 |
| Other | adult | 2–20 mcg/kg | IV | not captured | standing | page 31 |
| Sepsis | adult | 2–20 mcg/kg | IV | not captured | standing | page 110 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.01 mg/kg | IM | not captured | standing | page 43 |
| Anaphylaxis | adult | 0.01 mg/kg | IV | not captured | standing | page 43 |
| Anaphylaxis | adult | 0.3–0.5 mg | IV | not captured | standing | page 43 |
| Anaphylaxis | peds | 0.01 mg/kg | IV | not captured | standing | page 43 |
| Asthma / bronchospasm | adult | 0.01 mg/kg | IM | not captured | standing | page 62 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 62 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 62 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 27 |
| Cardiac arrest | adult | 0.01 mg/kg | IV/IO | not captured | standing | page 22 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 22 |
| Cardiac arrest | adult | 2 mg | ET | not captured | standing | page 22 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 22 |
| Croup | adult | 1 mg | NEB | not captured | standing | page 50 |
| Croup | peds | 1 mg | NEB | not captured | standing | page 50 |
| Other | adult | 0.3 mg | IM | not captured | standing | page 57 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1 mcg/kg | IV | not captured | standing | page 47 |
| Burns | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 94 |
| Burns | adult | 1 mcg/kg | IV/IO/IM | not captured | standing | page 94 |
| Burns | adult | 1 mcg/kg | IV/IO/IM | not captured | standing | page 94 |
| Burns | adult | 1.5 mcg/kg | IN | not captured | standing | page 94 |
| Burns | adult | 1.5 mcg/kg | IN | not captured | standing | page 94 |
| Burns | adult | 2 mcg/kg | IV/IO/IM/IN | not captured | standing | page 94 |
| Burns | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 94 |
| Burns | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 94 |
| Burns | peds | 1.5 mcg/kg | IN | not captured | standing | page 94 |
| Burns | peds | 1.5 mcg/kg | IN | not captured | standing | page 94 |
| Other | adult | 0.5 mcg/kg | IV/IO/IM/IN | not captured | standing | page 66 |
| Severe pain | adult | 1 mcg/kg | IV/IO/IM | not captured | standing | page 91 |
| Severe pain | adult | 1.5 mcg/kg | IN | not captured | standing | page 91 |
| Severe pain | adult | 2 mcg/kg | IV/IO/IM/IN | not captured | standing | page 91 |
| Severe pain | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 91 |
| Severe pain | peds | 1.5 mcg/kg | IN | not captured | standing | page 91 |
| Trauma / hemorrhage | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 91 |
| Trauma / hemorrhage | adult | 1 mcg/kg | IV/IO/IM | not captured | standing | page 91 |
| Trauma / hemorrhage | adult | 1.5 mcg/kg | IN | not captured | standing | page 91 |
| Trauma / hemorrhage | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 91 |
| Trauma / hemorrhage | peds | 1.5 mcg/kg | IN | not captured | standing | page 91 |
G–L Glucagon, Ipratropium, Ketamine, Ketorolac, Lidocaine5
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IM/IN | not captured | standing | page 43 |
| Hypoglycemia | adult | 0.5–1 mg | IM | not captured | standing | page 55 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | page 55 |
| Hypoglycemia | peds | 0.5–1 mg | IM | not captured | standing | page 55 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | NEB | not captured | standing | page 43 |
| Respiratory distress | adult | 0.5 mg | NEB | not captured | standing | page 60 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV | not captured | standing | page 97 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 97 |
| Other | adult | 1 mg/kg | IV | not captured | standing | page 31 |
| Other | adult | 1.5 mg/kg | IM/IN | not captured | standing | page 97 |
| Other | adult | 1.5 mg/kg | IN | not captured | standing | page 97 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 97 |
| Other | peds | 1.5 mg/kg | IN | not captured | standing | page 97 |
| Severe pain | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 94 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 30 mg | IV/IM | not captured | standing | page 153 |
| Mild to moderate pain | adult | 60 mg | IM | not captured | standing | page 153 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg | IV | not captured | standing | page 151 |
| Other | adult | 1–1.5 mg/kg | IV | not captured | standing | page 32 |
| Other | adult | 1 mg/kg | IV | not captured | standing | page 32 |
| Other | adult | 20–40 mg | IV | not captured | standing | page 151 |
| Other | peds | 0.5 mg/kg | IV | not captured | standing | page 151 |
| Other | peds | 1 mg/kg | IV | not captured | standing | page 32 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV | not captured | standing | page 32 |
| Wide-complex tachycardia | adult | 1 mg/kg | IV | not captured | standing | page 32 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV | not captured | standing | page 32 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV | not captured | standing | page 37 |
| VF / pulseless VT | adult | 1 mg/kg | IV | not captured | standing | page 37 |
| VF / pulseless VT | peds | 1 mg/kg | IV | not captured | standing | page 37 |
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Ondansetron, Oral Glucose8
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 62 |
| Asthma / bronchospasm | adult | 25–50 mg/kg | IV/IO | not captured | standing | page 62 |
| Asthma / bronchospasm | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 62 |
| COPD | adult | 2 g | IV | not captured | standing | page 63 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV | not captured | standing | page 130 |
| VF / pulseless VT | adult | 1–2 g | IV | not captured | standing | page 36 |
| VF / pulseless VT | adult | 25–50 mg/kg | IV/IO | not captured | standing | page 36 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 36 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 2 mg/kg | IV/IO/IM | not captured | standing | page 137 |
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | page 43 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | page 62 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 155 |
| Hyperactive delirium | adult | 2–5 mg | IV/IM/IN | not captured | standing | page 155 |
| Hyperactive delirium | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 155 |
| Other | adult | 0.1 mg/kg | not captured | not captured | standing | page 31 |
| Other | adult | 2–5 mg | IV | not captured | standing | page 31 |
| Other | peds | 0.1 mg/kg | not captured | not captured | standing | page 31 |
| Procedural sedation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 146 |
| Procedural sedation | adult | 2–5 mg | IV/IN | not captured | standing | page 146 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 146 |
| RSI induction | adult | 1 mg | IV | not captured | standing | page 147 |
| Seizure | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 65 |
| Seizure | adult | 2–5 mg | IV/IO/IN | not captured | standing | page 65 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 65 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2 mg | IV | not captured | standing | page 47 |
| CHF / pulmonary edema | adult | 2–4 mg | IV | not captured | standing | page 49 |
| Other | adult | 0.2 mg/kg | not captured | not captured | standing | page 66 |
| Other | adult | 2 mg | IV | not captured | standing | page 66 |
| Other | peds | 0.2 mg/kg | not captured | not captured | standing | page 66 |
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 104 |
| Mild to moderate pain | adult | 0.2 mg/kg | IV/IO | not captured | standing | page 104 |
| Mild to moderate pain | adult | 4 mg | IV/IO/IM | not captured | standing | page 104 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 104 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 104 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV | not captured | standing | page 13 |
| Other | adult | 0.5 mg | IV | not captured | standing | page 13 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 13 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 46 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 49 |
| Other | adult | 1 inch | TD | not captured | standing | page 54 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.1 mg/kg | IV/IM | not captured | standing | page 59 |
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 59 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 59 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 55 |
P–R Promethazine1
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 59 |
| Nausea / vomiting | adult | 12.5 mg | IV | not captured | standing | page 59 |
| Nausea / vomiting | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 59 |
S–Z Sodium Bicarbonate, Thiamine, Vasopressin3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 0.5 mEq/kg | IV | not captured | standing | page 13 |
| Cardiac arrest | adult | 1–1.5 mEq/kg | IV | not captured | standing | page 13 |
| Cardiac arrest | peds | 0.5 mEq/kg | IV | not captured | standing | page 13 |
| Crush injury | adult | 1 mEq/kg | IV/IO | not captured | standing | page 113 |
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 113 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | page 113 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 13 |
| Tricyclic overdose | adult | 0.5 mEq/kg | IV | not captured | standing | page 84 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | page 84 |
| Tricyclic overdose | peds | 0.5 mEq/kg | IV | not captured | standing | page 84 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV | not captured | standing | page 45 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 unit | IV/IO | not captured | standing | page 5 |
Cite this
Wilson County Emergency Management Agency, United States EMS Protocol Census. 177 dose entries, effective 2015-06-01.
https://protoquiz.com/census/agencies/wilson-county-emergency-management-agency/
The census is free and not for sale. Only public agencies are named.